Memorial Sloan Kettering Cancer Center
Mark Ewalt is currently the Associate Medical Director for Laboratory Operations and Associate Attending Pathologist at Memorial Sloan Kettering Cancer Center, with additional responsibilities as Program Director for the Molecular Genetic Pathology Fellowship. Prior experience includes positions as Associate Laboratory Director at the Colorado Molecular Correlates Laboratory and Assistant Professor at the University of Colorado Anschutz Medical Campus, where Mark also directed the Molecular Genetic Pathology Fellowship and led the Hematologic Malignancies section. Mark has held teaching and clinical roles at Cedars-Sinai and Stanford University School of Medicine, specializing in hematopathology and molecular genetic pathology. Mark's medical training includes a Doctor of Medicine from Columbia University and a Bachelor's Degree in Biology from Brown University.
This person is not in any teams
This person is not in any offices
Memorial Sloan Kettering Cancer Center
9 followers
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.